Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Project Grant - Priority Announcement: Infection and Immunity

Université Laval

$100,000.00

Pathogenic roles of platelets in sepsis.

FY 2019-20

Summary
Billions of platelets patrol blood vessels on the ready to prevent the loos of blood when a vessel is injured. The prevention of bleedings is the primarily recognized role of platelets, known since their first description in the late 19th century. When microbes such as bacteria enter the blood circulation, it generates multiple reactions such as fever, loss of blood pressure, alteration of heart rate and respiration. With their abundance in blood, platelets are chiefly positioned to interact with bacteria in blood. During blood invasion by bacteria, called sepsis, it is recognized that the platelet number diminishes dramatically. Moreover, platelets form aggregates in blood vessels during sepsis. However, how exactly platelets contribute to the pathogenesis in sepsis is not fully understood. We recently developed a novel mouse model of sepsis. In this model, we observed the formation of platelet aggregates in lungs and brain, and we noticed a dramatic reduction of platelet number in circulation. Herein in this application, we wish to utilize our model to determine how platelets may contribute to sepsis pathogenesis and we wish to interfere in the process. For this, we will use compelling mouse models of blood infections (sepsis) and we will administer drugs that target platelets. Using genetic and pharmacological approaches, we wish to improve the success of the therapies to combat infections. At the end of this project, we will have identified how platelets modify responses in blood-borne infections and how manipulating platelets can improve success in clinic.
Program
Project Grant - Priority Announcement: Infection and Immunity
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
414884
Name
Boilard Eric
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Cardiovascular System - C: Vascular System
Projecttitle
Pathogenic roles of platelets in sepsis.
Programtype2
Operating Grants
Orgnameinp2
Université Laval
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Project Grant - Priority Announcement: Infection and Immunity
Keyworddelim
Hemostasis; Platelets; Serotonin; Thrombocytopenia; Thrombosis; Vasculature; Vasodilatation
Abstract
Billions of platelets patrol blood vessels on the ready to prevent the loos of blood when a vessel is injured. The prevention of bleedings is the primarily recognized role of platelets, known since their first description in the late 19th century. When microbes such as bacteria enter the blood circulation, it generates multiple reactions such as fever, loss of blood pressure, alteration of heart rate and respiration. With their abundance in blood, platelets are chiefly positioned to interact with bacteria in blood. During blood invasion by bacteria, called sepsis, it is recognized that the platelet number diminishes dramatically. Moreover, platelets form aggregates in blood vessels during sepsis. However, how exactly platelets contribute to the pathogenesis in sepsis is not fully understood. We recently developed a novel mouse model of sepsis. In this model, we observed the formation of platelet aggregates in lungs and brain, and we noticed a dramatic reduction of platelet number in circulation. Herein in this application, we wish to utilize our model to determine how platelets may contribute to sepsis pathogenesis and we wish to interfere in the process. For this, we will use compelling mouse models of blood infections (sepsis) and we will administer drugs that target platelets. Using genetic and pharmacological approaches, we wish to improve the success of the therapies to combat infections. At the end of this project, we will have identified how platelets modify responses in blood-borne infections and how manipulating platelets can improve success in clinic.
Competitiondate
201909
Approvedterm2
1 yr 0 mth
Pinamesdelim
Boilard, Eric
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~
Université Laval - $100,000 Grant (2019-20) | Canada Spends